Anti-apoptotic effects of curcumin on photosensitized human epidermal carcinoma A431 cells

J Cell Biochem. 2004 May 1;92(1):200-12. doi: 10.1002/jcb.20059.

Abstract

Photodynamic treatment (PDT) can elicit a diverse range of cellular responses, including apoptotic cell death. Previously, we showed that PDT stimulates caspase-3 activation and subsequent cleavage and activation of p21-activated kinase 2 (PAK2) in human epidermal carcinoma A431 cells. Curcumin, the yellow pigment of Curcuma longa, is known to have anti-oxidant and anti-inflammatory properties. In the present study, using Rose Bengal (RB) as the photosensitizer, we investigated the effect of curcumin on PDT-induced apoptotic events in human epidermal carcinoma A431 cells. We report that curcumin prevented PDT-induced JNK activation, mitochondrial release of cytochrome c, caspase-3 activation, and cleavage of PAK2. Using the cell permeable dye DCF-DA as an indicator of reactive oxygen species (ROS) generation, we found that both curcumin and ROS scavengers (i.e., l-histidine, a-tocopherol, mannitol) abolished PDT-stimulated intracellular oxidative stress. Moreover, all these PDT-induced apoptotic changes in cells could be blocked by singlet oxygen scavengers (i.e., l-histidine, a-tocopherol), but were not affected by the hydroxyl radical scavenger mannitol. In addition, we found that SP600125, a JNK-specific inhibitor, reduced PDT-induced JNK activation as well as caspase-3 activation, indicating that JNK activity is required for PDT-induced caspase activation. Collectively, these results demonstrate that singlet oxygen triggers JNK activation, cytochrome c release, caspase activation and subsequent apoptotic biochemical changes during PDT and show that curcumin is a potent inhibitor for this process.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / drug effects*
  • Carcinoma / drug therapy
  • Carcinoma / metabolism*
  • Caspase 3
  • Caspase Inhibitors
  • Caspases / metabolism
  • Cell Line, Tumor
  • Curcumin / pharmacology*
  • Curcumin / therapeutic use
  • Cytochromes c / metabolism
  • Enzyme Activation / drug effects
  • Humans
  • JNK Mitogen-Activated Protein Kinases / metabolism
  • MAP Kinase Kinase 4
  • Mitogen-Activated Protein Kinase Kinases / metabolism
  • Oxidative Stress / drug effects
  • Photochemotherapy*
  • Poly(ADP-ribose) Polymerases / metabolism
  • Protein Serine-Threonine Kinases / metabolism
  • Reactive Oxygen Species / analysis
  • alpha-Tocopherol / pharmacology
  • p21-Activated Kinases

Substances

  • Caspase Inhibitors
  • Reactive Oxygen Species
  • Cytochromes c
  • Poly(ADP-ribose) Polymerases
  • PAK2 protein, human
  • Protein Serine-Threonine Kinases
  • p21-Activated Kinases
  • JNK Mitogen-Activated Protein Kinases
  • MAP Kinase Kinase 4
  • Mitogen-Activated Protein Kinase Kinases
  • CASP3 protein, human
  • Caspase 3
  • Caspases
  • alpha-Tocopherol
  • Curcumin